https://techilive.in/catalyst-pharmaceuticals-comments-on-fdas-announcement-of-its-position-on-orphan-drug-exclusivity-in-light-of-the-11th-circuit-decision-in-catalyst-pharmaceuticals-inc-v-becerra/